TURNOVER (x1000 DKK)
NET PROFIT (x1000 DKK)
EMPLOYEES
Promega Biotech AB
Closing information (x1000 DKK)
| Closing information | 2025/03 | 2024/03 | 2023/03 |
| Turnover |
79,627
|
62,753
|
58,035 |
| Financial expenses |
21
|
0
|
0 |
| Earnings before taxes |
6,470
|
8,603
|
8,331 |
| EBITDA |
6,518
|
8,652
|
8,438 |
| Total assets |
34,098
|
23,839
|
28,220 |
| Current assets |
33,975
|
23,739
|
28,077 |
| Current liabilities |
12,873
|
8,718
|
6,683 |
| Equity capital |
19,078
|
13,165
|
19,770 |
| - share capital |
69
|
65
|
66 |
| Employees (average) |
10
|
10
|
10 |
Financial ratios
| Fiscal year | 2025/03 | 2024/03 | 2023/03 |
| Solvency |
56.0%
|
55.2%
|
70.1% |
| Turnover per employee |
7,963
|
6,275
|
5,804 |
| Profit as a percentage of turnover |
8.1%
|
13.7%
|
14.4% |
| Return on assets (ROA) |
19.0%
|
36.1%
|
29.5% |
| Current ratio |
263.9%
|
272.3%
|
420.1% |
| Return on equity (ROE) |
33.9%
|
65.3%
|
42.1% |
| Change turnover |
12,934
|
5,902
|
3,039 |
| Change turnover % |
19%
|
10%
|
6% |
| Chg. No. of employees |
0
|
0
|
0 |
| Chg. No. of employees % |
0%
|
0%
|
0% |
Total value of public sale
| Fiscal year | 2025/03 | 2024/03 | 2023/03 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.